Chromogranin A and other enteroendocrine markers in inflammatory bowel disease

被引：18
|
作者：
Massironi, Sara [1 ]
Zilli, Alessandra [1 ,2 ]
Cavalcoli, Federica [1 ,2 ]
Conte, Dario [1 ,2 ]
Peracchi, Maddalena [1 ,2 ]
机构：
[1] Fdn IRCCS Ca Granda Osped Maggiore Policlin, Gastroenterol & Endoscopy Unit, Via F Sforza 35, I-20122 Milan, Italy
[2] Univ Milan, Postgrad Sch Gastroenterol, Dept Pathophysiol & Transplantat, I-20122 Milan, Italy
来源：
NEUROPEPTIDES | 2016年 / 58卷
关键词：
Chromogranin A; Enteroendocrine cell; Inflammatory bowel disease; Crohn's disease; Ulcerative colitis; VASOACTIVE-INTESTINAL-PEPTIDE; CHRONIC ULCERATIVE-COLITIS; ATYPICAL CARCINOID-TUMOR; NEUROPEPTIDE-Y NPY; SUBSTANCE-P; CROHNS-DISEASE; ION-TRANSPORT; IMMUNOREACTIVE SOMATOSTATIN; PANCREATIC-POLYPEPTIDE; GASTROINTESTINAL-TRACT;
D O I：
10.1016/j.npep.2016.01.002
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
Changes in the distribution and products of enteroendocrine cells may play a role in immune activation and regulation of gut inflammation. This review aims at critically evaluating the main enteroendocrine markers in inflammatory bowel diseases (IBD). A narrative review was performed by searching inflammatory bowel diseases and enteroendocrine biomarkers in PubMed. Relevant modifications of some enteroendocrine markers, such as Chromogranin A, and their correlation with disease activity have been reported in patients with inflammatory bowel diseases. Even if data about neuroendocrine markers are sometimes contrasting, they may be potentially useful for the diagnosis and clinical management of these patients. (C) 2016 Elsevier Ltd. All rights reserved.
引用
收藏
页码：127 / 134
页数：8
相关论文
共 50 条
  • [31] Biological markers of disease activity in inflammatory bowel diseases
    Szymanska, Edyta
    Szymanska, Sylwia
    Dadalski, Maciej
    Kierkus, Jaroslaw
    GASTROENTEROLOGY REVIEW-PRZEGLAD GASTROENTEROLOGICZNY, 2023, 18 (02): : 141 - 147
  • [32] Microbiome markers of biological therapy in inflammatory bowel disease
    Zhao, Xiaolei
    Xu, Jun
    Liu, Yulan
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2023, 38 : 111 - 111
  • [33] Update of fecal markers of inflammation in inflammatory bowel disease
    Judd, Thomas A.
    Day, Andrew S.
    Lemberg, Daniel A.
    Turner, Dan
    Leach, Steven T.
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2011, 26 (10) : 1493 - 1499
  • [34] Genetic markers and pediatric onset inflammatory bowel disease
    Mansukhani, M.
    Schwartz, J.
    Twaddell, W. S.
    Martinez, M.
    Remotti, H.
    MODERN PATHOLOGY, 2008, 21 : 129A - 129A
  • [35] Role of laboratory markers in paediatric inflammatory bowel disease
    Shentova, R.
    Yaneva, P.
    Baycheva, M.
    Hadjiiski, P.
    Kofinova, D.
    Zhelev, C.
    JOURNAL OF CROHNS & COLITIS, 2018, 12 : S456 - S456
  • [36] SUBCLINICAL MARKERS OF HUMAN INFLAMMATORY BOWEL-DISEASE
    YANG, HY
    ROTTER, JI
    CANADIAN JOURNAL OF GASTROENTEROLOGY, 1995, 9 (03): : 161 - 167
  • [37] Role of serologic markers in diagnosis of inflammatory bowel disease
    Gasilionis, V
    Paner, GP
    Kahn, SE
    Hammadeh, R
    Holmes, EW
    MODERN PATHOLOGY, 2005, 18 : 103A - 103A
  • [38] Propanediol utilization genes as inflammatory bowel disease markers
    Baikova, I.
    Rakitina, D.
    Garanina, I.
    Danilova, N.
    Abdulkhakov, S.
    Grigoryeva, T.
    Markelova, M.
    Odintsova, A.
    Abdulkhakov, R.
    Scherbakov, P.
    Govorun, V.
    FEBS OPEN BIO, 2018, 8 : 245 - 246
  • [39] A critical evaluation of serologic markers for inflammatory bowel disease
    Austin, Gregory L.
    Herfarth, Hans H.
    Sandler, Robert S.
    CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2007, 5 (05) : 545 - 547
  • [40] Biological markers of activity in the inflammatory bowel disease.
    Lombrana, JLS
    Palacio, MA
    Carbajal, C
    Vivas, S
    Perez, R
    Rodrigo, L
    REVISTA ESPANOLA DE ENFERMEDADES DIGESTIVAS, 1997, 89 (11) : 855 - 858
12345